.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Apollo Hospitals has officially launched the Apollo Dadar Speciality Centre in Mumbai to broaden access to high-quality healthcare. This strategic expansion aims to bridge the gap for thousands of patients who currently travel long distances for treatment. Consequently, Mumbai residents can now access world-class medical expertise without the burden of extensive commuting. This facility represents a significant milestone in Apollo's commitment to patient-centric infrastructure.
Currently, nearly 8,000 patients from Mumbai travel to the Navi Mumbai facility every year. This journey often involves a 30-kilometre commute per visit, which is particularly taxing for those with chronic illnesses. Therefore, the new centre in Dadar serves as a vital hub for continuity of care. Moreover, it ensures that oncology and transplant patients receive consistent follow-ups closer to their homes. Apollo Hospitals believes that world-class healthcare must be consistently accessible to all.
The facility integrates advanced diagnostics with robotics-enabled care. Furthermore, patients will benefit from 24/7 clinical access and integrated care pathways. Because the centre focuses on super-speciality services, it caters to complex medical needs efficiently. Specifically, the launch coincides with the 10th anniversary of Apollo Navi Mumbai. As a result, the healthcare provider continues to strengthen its presence across the Mumbai Metropolitan Region.
The centre provides a wide array of super-speciality services to meet diverse patient requirements. These include cardiology, neurology, and oncology. Additionally, the facility offers specialized care in gastroenterology, orthopaedics, and pulmonology. Patients requiring organ transplant follow-ups will also find dedicated support here. Thus, the Dadar centre functions as a comprehensive medical destination for advanced therapeutic interventions and diagnostics.
Q1: What specific medical specialities are available at the new Dadar centre?
The centre offers services in cardiology, neurology, oncology, gastroenterology, orthopaedics, transplantation, and pulmonology, supported by robotics-enabled care and diagnostics.
Q2: Why did Apollo Hospitals choose Dadar for this expansion?
Apollo chose Dadar to reduce the travel burden for nearly 8,000 Mumbai-based patients who previously commuted 30 kilometres to Navi Mumbai for advanced treatment.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Apollo Hospitals opens a Super Speciality Centre in Dadar, Mumbai, offering cardiology, oncology, and robotics-enabled care to improve patient access....
5 months ago
A breakthrough study evaluated H5N1 transmission efficiency across mammalian isolates. Researchers discovered that human-derived D1.1 harboring the PB2 D701N mutation spread efficiently in ferrets, unlike strains carrying PB2 E627K. This finding highlights critical genetic markers for zoonotic surveillance.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
